Pediatrics (System-Integrated)

Neonatal hyperbilirubinemia: pathologic vs physiologic

Clinical Overview and When to Suspect Neonatal Hyperbilirubinemia

— Physiologic jaundice: appears after 24 hours of life, peaks day 3-5 (term) or day 5-7 (preterm), resolves by 1-2 weeks, TSB usually <15 mg/dL, indirect/unconjugated predominant

— Pathologic jaundice: any of — onset <24 h, TSB rising >0.2 mg/dL/hr or >5 mg/dL/day, TSB above the AAP hour-specific nomogram threshold, direct bilirubin >1 mg/dL (or >20% of TSB), persistent jaundice >2 weeks (term) or >3 weeks (preterm), or any signs of underlying illness

— Jaundice noted in the delivery room or first 24 hours → always pathologic until proven otherwise (think hemolysis: ABO/Rh, G6PD)

— Sick-appearing neonate with jaundice → sepsis, congenital infection, metabolic disease

— Pale stools + dark urine + jaundice beyond 2 weeks → biliary atresia (direct hyperbilirubinemia, surgical emergency)

— Exclusively breastfed infant with poor weight gain and jaundice day 3-7 → breastfeeding (suboptimal intake) jaundice

Board pearl: The single most important first question is "How old is this baby in hours?" — the AAP nomogram is hour-specific, not day-specific, and treatment thresholds shift dramatically between hour 24 and hour 72.

Definition: Total serum bilirubin (TSB) elevation in neonates, clinically visible jaundice when TSB >5 mg/dL, typically progressing cephalocaudally from face → trunk → extremities → soles

Epidemiology: ~60% of term and ~80% of preterm neonates develop visible jaundice in the first week; severe hyperbilirubinemia (TSB >25 mg/dL) occurs in ~1:700 births

Why it matters: Unconjugated bilirubin is lipophilic and crosses the blood-brain barrier → acute bilirubin encephalopathy (ABE) and irreversible kernicterus (choreoathetoid CP, sensorineural hearing loss, gaze palsy, dental dysplasia)

Two fundamental categories to separate at the bedside:

High-suspicion clinical scenarios on Step 3:

Presentation Patterns and Key History

— <24 hours of life: ALWAYS pathologic — hemolytic disease (Rh isoimmunization, ABO incompatibility, G6PD deficiency, hereditary spherocytosis), congenital infection (TORCH), concealed hemorrhage (cephalohematoma, intracranial bleed)

— Day 2-3 (term), day 3-4 (preterm): Most consistent with physiologic jaundice; also breastfeeding jaundice from inadequate intake

— Day 4-7 onward, well infant: Breast milk jaundice (β-glucuronidase deconjugates bilirubin in gut → enterohepatic recirculation), may persist 4-12 weeks

— >2 weeks persistent jaundice: Workup mandatory — check fractionated bilirubin to rule out biliary atresia, choledochal cyst, neonatal hepatitis, hypothyroidism, galactosemia, UTI

— Maternal blood type and Rh, indirect Coombs, prenatal labs, GBS status

— Gestational age, birth weight, mode of delivery, instrumented delivery (vacuum/forceps → cephalohematoma)

— Feeding type and adequacy — number of wet diapers (≥6/day by day 4), stools, weight loss (>10% from birth weight is concerning)

— Family history: prior sibling with phototherapy or exchange transfusion, splenectomy, anemia, gallstones in childhood, Mediterranean/African/Asian ancestry (G6PD), Crigler-Najjar, Gilbert

— Ethnicity: East Asian infants have higher peak bilirubin

— Lethargy, poor feeding, high-pitched cry, hypertonia, retrocollis/opisthotonos → acute bilirubin encephalopathy

— Acholic (clay-colored) stools, dark urine → conjugated/direct hyperbilirubinemia

Key distinction: Breastfeeding jaundice = early (day 3-5), due to inadequate intake/dehydration, fix by increasing feeding frequency. Breast milk jaundice = later (day 5-14, can persist weeks), well-fed thriving infant, fix is reassurance — do NOT routinely stop breastfeeding.

Timing-based pattern recognition is the core Step 3 skill:

Essential history to obtain:

Red flag historical features:

Physical Exam Findings and Severity Assessment

— Face only: TSB ~5 mg/dL

— Upper trunk: ~10 mg/dL

— Lower trunk/thighs: ~12-15 mg/dL

— Arms/lower legs: ~15-18 mg/dL

— Palms and soles: >20 mg/dL — danger zone

— Visual estimation is unreliable in dark-skinned infants and after phototherapy — always confirm with TcB or TSB

— Phase 1 (early, reversible): Lethargy, hypotonia, poor suck

— Phase 2 (intermediate): Hypertonia of extensor muscles, retrocollis (backward neck arching), opisthotonos, fever, high-pitched cry — medical emergency, escalate immediately

— Phase 3 (advanced, often irreversible): Apnea, seizures, coma, deep stupor, death

— Pallor + tachycardia → hemolytic anemia

— Petechiae, purpura → TORCH, DIC, sepsis

— Abdominal distension + bilious emesis → intestinal obstruction with enterohepatic recirculation

Step 3 management: Any neonate with retrocollis, opisthotonos, or high-pitched cry — initiate intensive phototherapy immediately, draw STAT TSB, type & cross, and prepare for exchange transfusion. Do not wait for confirmatory labs to start phototherapy in suspected ABE.

Visual assessment of jaundice (Kramer's rule — cephalocaudal progression):

Examination technique: Blanch skin over the forehead, sternum, or knee with finger pressure in natural light; assess sclera and oral mucosa

Hepatosplenomegaly: Hemolysis, congenital infection, storage disease, biliary obstruction

Cephalohematoma/bruising: Resorbing blood → bilirubin load; subgaleal hemorrhage can be life-threatening

Microcephaly, chorioretinitis, rash ("blueberry muffin"): Congenital CMV, toxoplasmosis, rubella

Dysmorphic features: Trisomy 21 (increased hyperbilirubinemia risk), Alagille syndrome

Neurologic exam — staging of acute bilirubin encephalopathy (BIND score):

Signs of underlying etiology:

Diagnostic Workup — Initial Labs

— Transcutaneous bilirubin (TcB): Screening tool, accurate when TSB <15 mg/dL and before phototherapy; if elevated, confirm with serum

— Total serum bilirubin (TSB) with fractionation (direct/conjugated): Gold standard

— Plot TSB on the AAP 2022 hour-specific nomogram using gestational age and neurotoxicity risk factors (isoimmune hemolysis, G6PD deficiency, sepsis, significant lethargy, temperature instability, acidosis, albumin <3 g/dL)

— CBC with smear: Anemia + reticulocytosis = hemolysis; spherocytes (hereditary spherocytosis or ABO), bite cells (G6PD), schistocytes (microangiopathic)

— Reticulocyte count: Elevated in hemolysis

— Blood type and Rh of infant + direct Coombs (DAT): Positive DAT confirms isoimmune hemolysis (Rh, ABO, minor antigens)

— Maternal blood type, Rh, antibody screen if not already known

— Peripheral smear

— G6PD activity: Especially in male infants of Mediterranean, African, Middle Eastern, or Southeast Asian descent

— Albumin: Bilirubin/albumin ratio refines exchange transfusion threshold

— LFTs (AST, ALT, GGT, alkaline phosphatase)

— TSH and free T4 (congenital hypothyroidism, on newborn screen)

— Urinalysis and urine culture (UTI is a classic occult cause)

— Urine reducing substances (galactosemia)

— Newborn screen results review

— Septic workup if ill-appearing: CBC, blood/urine/CSF cultures

Board pearl: A positive direct Coombs in an ABO setup (mom O, baby A or B) is the most common cause of isoimmune hemolytic disease in the US today since RhoGAM essentially eliminated Rh disease.

Step 1 — Confirm and quantify bilirubin:

Step 2 — If TSB elevated or jaundice <24 h or rising rapidly:

Step 3 — If direct bilirubin >1 mg/dL or >20% of TSB (conjugated hyperbilirubinemia):

Hour-of-life recheck cadence: TSB rising >0.2 mg/dL/hr → recheck q4-6 h until plateau

Diagnostic Workup — Advanced and Confirmatory Studies

— Abdominal ultrasound: Look for absent/contracted gallbladder, "triangular cord sign" (fibrous remnant at porta hepatis), choledochal cyst, gallstones

— Hepatobiliary scintigraphy (HIDA scan) with phenobarbital pretreatment: Failure of tracer excretion into bowel at 24 h suggests biliary atresia

— Liver biopsy: Bile duct proliferation, portal fibrosis, bile plugs — gold standard before surgery

— Intraoperative cholangiogram: Definitive diagnosis of biliary atresia

— UGT1A1 mutation testing: Crigler-Najjar (types I and II), Gilbert syndrome

— Galactose-1-phosphate uridyltransferase activity: Galactosemia

— Alpha-1 antitrypsin level and phenotype (PiZZ): Neonatal cholestasis

— Sweat chloride / CFTR: Cystic fibrosis with neonatal cholestasis

— Bile acid synthesis panel, urine organic acids, plasma amino acids

— TORCH titers, CMV urine PCR, hepatitis serologies, syphilis VDRL

— Osmotic fragility test or eosin-5-maleimide flow cytometry: Hereditary spherocytosis

— Hemoglobin electrophoresis: Alpha-thalassemia (presents earlier than beta)

— Pyruvate kinase activity: PK deficiency

Key distinction: Direct (conjugated) hyperbilirubinemia in a neonate is NEVER physiologic — it always warrants urgent workup, with biliary atresia as the can't-miss diagnosis given its narrow surgical window.

For conjugated (direct) hyperbilirubinemia — must evaluate for biliary atresia rapidly (Kasai portoenterostomy outcomes best if performed <60 days of life):

Genetic and metabolic studies (selected):

For unexplained persistent unconjugated hyperbilirubinemia:

End-tidal carbon monoxide (ETCOc): Specialty centers; quantifies heme catabolism rate (research/select use)

Auditory brainstem response (ABR/BAER): All infants with TSB requiring exchange transfusion or with neurologic signs → screens for bilirubin-induced auditory neuropathy

MRI brain: In suspected kernicterus → T2 hyperintensity of bilateral globus pallidus and subthalamic nuclei

Risk Stratification and First-Line Management Logic

— Gestational age (35-36 wk, 37-38 wk, ≥38 wk thresholds differ)

— Hour-specific TSB

— Presence of neurotoxicity risk factors: Isoimmune hemolytic disease, G6PD deficiency, sepsis, clinical instability, albumin <3.0 g/dL, temperature instability, significant lethargy, acidosis

— TSB below phototherapy threshold and rate of rise normal → routine follow-up

— TSB at or above phototherapy threshold → initiate phototherapy

— TSB within 2 mg/dL of exchange threshold or any signs of ABE → escalate to intensive phototherapy + IVIG (if isoimmune) + prepare exchange transfusion

— TSB at exchange threshold or ABE present → immediate double-volume exchange transfusion

— Discharge <24 h → follow-up by 72 h of life

— Discharge 24-48 h → follow-up by 96 h

— Discharge 48-72 h → follow-up by 120 h

— Ensure feeding: 8-12 breastfeeds/day; supplement only if medically indicated, not routinely

— Avoid dextrose water or plain water (worsens hyperbilirubinemia by reducing caloric intake)

— Educate parents on jaundice progression and when to call

CCS pearl: When managing a CCS jaundice case, order TSB with fractionation + DAT + CBC + reticulocyte + blood type + albumin as a single initial bundle, then plot on the nomogram before deciding phototherapy versus observation.

AAP 2022 framework — every decision uses three inputs:

Decision tree:

Universal predischarge screening (AAP): All newborns get TcB or TSB before discharge; result plotted on nomogram to determine follow-up timing (within 24-48 h if higher risk zone)

Discharge timing rule:

Modifiable risk factors to address before discharge:

Major risk factors for severe hyperbilirubinemia (memorize): Predischarge TSB in high-risk zone, gestational age 35-37 wk, sibling with phototherapy, visible jaundice in first 24 h, isoimmune hemolytic disease, cephalohematoma/bruising, exclusive breastfeeding (especially if poor feeding/weight loss), East Asian race

Pharmacotherapy and Phototherapy — First-Line Treatment

— Mechanism: Blue-green light (wavelength 460-490 nm, peak ~460 nm) converts unconjugated bilirubin in skin to lumirubin and configurational isomers that are water-soluble and excreted in bile/urine without conjugation

— Intensive phototherapy: Irradiance ≥30 μW/cm²/nm over maximum body surface area; use LED or fluorescent units, fiberoptic blankets can be added

— Operational essentials: Eye protection, diaper-only exposure, maintain hydration, monitor temperature, continue breastfeeding (interruptions only if intake inadequate)

— Monitoring on phototherapy: TSB q4-6 h initially, then q12-24 h as it declines; do NOT use TcB during/immediately after phototherapy (unreliable)

— Discontinue phototherapy when TSB falls 2-3 mg/dL below treatment threshold; rebound TSB check 12-24 h later, especially in hemolytic disease or <38 weeks GA

— Indication: Isoimmune hemolytic disease (Rh, ABO with positive DAT) when TSB rises despite intensive phototherapy or is within 2-3 mg/dL of exchange threshold

— Dose: 0.5-1 g/kg IV over 2 h, may repeat in 12 h

— Mechanism: Blocks Fc receptors on reticuloendothelial macrophages → reduces hemolysis

— Hydration: Enteral feeding preferred; IV fluids only if dehydrated or unable to feed

— Treat underlying cause: Antibiotics for sepsis/UTI, hypothyroidism replacement, galactose-free formula for galactosemia

— Sunlight exposure as therapy (UV burn risk, unreliable dosing)

— Routine breastfeeding cessation (rarely, brief 24-48 h interruption + formula supplementation may be diagnostic/therapeutic in severe breast milk jaundice)

— Phenobarbital is not used acutely in neonates (used historically in Crigler-Najjar type II long-term)

Board pearl: Phototherapy is contraindicated in conjugated hyperbilirubinemia — direct bilirubin doesn't respond to phototherapy and can cause "bronze baby syndrome" (grayish-brown skin discoloration from porphyrin accumulation).

Phototherapy — the cornerstone of treatment:

IVIG (intravenous immunoglobulin):

Adjunctive measures:

NOT recommended/avoid:

Exchange Transfusion and Advanced Management

— Definitive treatment for severe hyperbilirubinemia unresponsive to intensive phototherapy or with signs of acute bilirubin encephalopathy

— Indications (AAP 2022):

— TSB at or above the exchange transfusion threshold on the hour-specific nomogram

— Any signs of intermediate or advanced ABE (hypertonia, retrocollis, opisthotonos, high-pitched cry, seizures) — regardless of TSB level

— TSB rising despite intensive phototherapy + IVIG in isoimmune disease

— Volume: ~160-200 mL/kg (twice the infant's blood volume) — replaces ~85% of circulating RBCs and removes ~50% of intravascular bilirubin

— Blood product: Reconstituted whole blood (PRBCs + FFP), Rh-negative and ABO-compatible with mother in isoimmune disease, CMV-negative, irradiated, leukoreduced, <7 days old

— Access: Umbilical venous catheter (preferred), isovolumetric technique

— Procedure pace: Small aliquots (5-20 mL depending on weight) over 1-2 h total

— Cardiac: Arrhythmias, volume overload, cardiac arrest

— Metabolic: Hypocalcemia (citrate), hyperkalemia, hypoglycemia, acidosis

— Hematologic: Thrombocytopenia, coagulopathy

— Infectious: Sepsis, bloodborne pathogen transmission

— Vascular: Portal vein thrombosis, NEC, air embolism

— TSB 2 h post-exchange, then q4-6 h

— Continue intensive phototherapy

— Monitor glucose, calcium, electrolytes, platelets, hemoglobin

— Kasai hepatoportoenterostomy for biliary atresia — outcomes best if performed before 60 days of life (10-year native liver survival ~50% if early); after 90 days, liver transplant often becomes inevitable

— Choledochal cyst excision

Step 3 management: Exchange transfusion is performed in a NICU with neonatology and blood bank involvement; on CCS, order "transfer to NICU," "type and crossmatch reconstituted whole blood," and "continuous cardiorespiratory monitoring" simultaneously.

Double-volume exchange transfusion (DVET):

Complications of exchange transfusion (~5-10% morbidity, mortality <0.5% in stable infants, up to 8% in sick infants):

Post-exchange monitoring:

Surgical management for conjugated hyperbilirubinemia:

Special Populations — Preterm Infants and Comorbid Conditions

— Lower phototherapy and exchange thresholds — use preterm-specific guidelines (e.g., NICHD/Maisels stratification by GA and birth weight)

— Increased blood-brain barrier permeability, lower albumin, more comorbidities (sepsis, acidosis) → kernicterus at lower TSB levels

— Higher peak bilirubin (often day 5-7) and slower clearance due to immature UGT1A1 enzyme

— Prophylactic phototherapy may be considered in ELBW infants (<1000 g)

— Avoid IV ceftriaxone (displaces bilirubin from albumin) — use cefotaxime if cephalosporin needed

— Hemolytic crises triggered by oxidative stress (sulfa drugs, naphthalene mothballs, fava beans via breast milk, infection)

— Often less reticulocytosis than expected → "hidden" hemolysis

— Lower phototherapy threshold per AAP 2022 (considered a neurotoxicity risk factor)

— Counsel family on lifelong oxidative-trigger avoidance

— Acidosis and hypoalbuminemia increase free bilirubin → lower neurotoxicity threshold

— Aggressive resuscitation reduces kernicterus risk

— Prolonged unconjugated hyperbilirubinemia; check newborn screen TSH; treat with levothyroxine 10-15 μg/kg/day — bilirubin normalizes within weeks

— Neonatal liver has reduced UGT1A1 activity (~1% of adult by day 1, ~100% by 14 weeks)

— Reduced biliary excretion + sterile gut + beta-glucuronidase activity → enterohepatic circulation amplifies unconjugated bilirubin load

— Type I: Absent UGT1A1, requires lifelong phototherapy, liver transplant curative

— Type II (Arias): Partial deficiency, responds to phenobarbital (induces residual UGT1A1)

Key distinction: Gilbert syndrome rarely causes neonatal hyperbilirubinemia alone but synergizes with G6PD, hereditary spherocytosis, or breastfeeding to produce clinically significant jaundice.

Preterm infants (especially <35 weeks GA):

Infants with G6PD deficiency:

Infants with sepsis or hypoxic-ischemic encephalopathy:

Infants with congenital hypothyroidism:

Renal/hepatic immaturity in all neonates:

Crigler-Najjar syndrome:

Special Populations — Maternal Factors and Family-Centered Considerations

— Administer RhoGAM (anti-D immune globulin) at 28 weeks gestation and within 72 h postpartum if infant is Rh-positive — prevents future Rh isoimmunization

— Also indicated after any sensitizing event (miscarriage, amniocentesis, abdominal trauma, ectopic pregnancy)

— If mother already sensitized (positive indirect Coombs in pregnancy), monitor with MCA Doppler for fetal anemia, intrauterine transfusion if needed

— Most common isoimmune cause in the US (mother O, baby A or B)

— Cannot be prevented — anticipate and monitor with predischarge TSB and DAT

— Generally milder than Rh disease; rarely requires exchange transfusion

— Infants of diabetic mothers (IDM) have polycythemia → increased RBC turnover → hyperbilirubinemia

— Also at risk for hypoglycemia, macrosomia, RDS

— AAP and ABM strongly recommend continuing breastfeeding even during phototherapy

— Lactation consultant referral if poor latch or weight loss >7-10%

— Formula supplementation indicated only when intake inadequate after lactation support

— Parents may use folk remedies (herbal teas, sunlight exposure, oil rubs) — assess and counsel without judgment

— Use professional interpreters, not family members

— Increased recurrence risk; consider closer monitoring and earlier predischarge bilirubin check

— Appropriate for select term, well-appearing infants with moderate hyperbilirubinemia, reliable family, and TSB monitoring access

— Not appropriate for hemolytic disease or TSB near exchange threshold

Board pearl: A G6PD-deficient infant breastfed by a mother who eats fava beans can hemolyze through breast milk transfer — and naphthalene mothballs in stored baby clothing are a classic Step 3 trigger.

Rh-negative mothers:

ABO incompatibility:

Maternal diabetes:

Breastfeeding support:

Cultural and linguistic considerations:

Siblings with history of phototherapy or exchange transfusion:

Home phototherapy:

Complications and Adverse Outcomes

— Phase 1 (early): Hypotonia, lethargy, poor suck — potentially reversible with prompt exchange transfusion

— Phase 2 (intermediate): Hypertonia, retrocollis, opisthotonos, high-pitched cry, fever — partially reversible; aggressive intervention can prevent kernicterus

— Phase 3 (advanced): Apnea, seizures, coma — usually leads to chronic kernicterus or death

— Classic tetrad: (1) choreoathetoid cerebral palsy, (2) sensorineural hearing loss / auditory neuropathy spectrum disorder, (3) upward gaze palsy, (4) dental enamel dysplasia

— Caused by bilirubin deposition in basal ganglia (especially globus pallidus, subthalamic nuclei), hippocampus, brainstem nuclei

— MRI: T2 hyperintensity of bilateral globus pallidus

— Intelligence often preserved — a tragic, preventable disability

— Subtle neurodevelopmental and auditory processing deficits in infants exposed to moderately elevated TSB without classic kernicterus

— Hyperthermia, dehydration, loose stools, retinal damage (use eye shields), transient rash, parent-infant bonding disruption, bronze baby syndrome (if conjugated bilirubinemia present)

— Untreated biliary atresia → biliary cirrhosis, portal hypertension, liver failure by age 2

— Untreated congenital hypothyroidism → cretinism (intellectual disability, short stature)

— Untreated galactosemia → cataracts, liver failure, sepsis (E. coli), intellectual disability

— ALL infants who received exchange transfusion or had TSB at/above exchange threshold → automated ABR prior to discharge and outpatient audiology follow-up

Key distinction: Kernicterus is now considered a "never event" — every case is preventable with universal predischarge screening, hour-specific nomogram use, and appropriate phototherapy thresholds.

Acute bilirubin encephalopathy (ABE):

Chronic kernicterus (bilirubin encephalopathy):

Bilirubin-induced neurologic dysfunction (BIND):

Complications of phototherapy:

Complications of exchange transfusion: Detailed in chunk 8 — cardiac arrest, electrolyte disturbances, infection, NEC, thrombocytopenia

Long-term sequelae of underlying causes:

Hearing loss screening:

When to Escalate Care — NICU, Consultation, and Inpatient Triage

— Any sign of acute bilirubin encephalopathy (hypertonia, retrocollis, opisthotonos, high-pitched cry, seizures, apnea)

— TSB approaching or at exchange transfusion threshold

— Need for exchange transfusion preparation

— Hemodynamic instability, sepsis, severe anemia (Hgb <10 g/dL with hemolysis)

— Preterm infant requiring intensive phototherapy

— TSB significantly above threshold

— Hemolytic disease (rising despite phototherapy)

— Conjugated hyperbilirubinemia under workup

— Inadequate feeding/dehydration requiring IV fluids

— Social concerns or unreliable follow-up

— Preterm or comorbid conditions

— Neonatology: Severe hyperbilirubinemia, exchange transfusion candidates

— Pediatric hematology: Suspected hemolytic anemia of unclear etiology, G6PD/hereditary spherocytosis confirmation

— Pediatric gastroenterology/hepatology: Direct hyperbilirubinemia, suspected biliary atresia

— Pediatric surgery: Biliary atresia (Kasai), choledochal cyst

— Endocrinology: Congenital hypothyroidism, panhypopituitarism

— Genetics/metabolism: Suspected inborn error of metabolism

— Audiology and developmental pediatrics: Post-exchange or post-severe-hyperbilirubinemia follow-up

— Lactation consultant: Breastfeeding optimization

— Early involvement when exchange transfusion likely — reconstituted whole blood preparation takes time

— Type & crossmatch with maternal serum in isoimmune disease

— TSB >2 mg/dL above intensive phototherapy threshold and rising

— Need for exchange transfusion not available locally

— Suspected biliary atresia (time-sensitive surgical referral)

CCS pearl: On a CCS exchange-transfusion case, simultaneously (1) start intensive phototherapy, (2) order labs (TSB, DAT, CBC, type & cross, albumin, glucose, calcium), (3) consult NICU/neonatology, (4) notify blood bank, (5) give IVIG if isoimmune hemolysis confirmed. Don't wait sequentially.

Immediate NICU transfer indications:

Inpatient admission for phototherapy (rather than home phototherapy):

Subspecialty consultations:

Blood bank coordination:

Transfer criteria from community hospital → tertiary care:

Key Differentials — Other Causes of Unconjugated Hyperbilirubinemia

— Isoimmune: Rh incompatibility (severe, can cause hydrops fetalis), ABO incompatibility (most common in US), minor blood group antibodies (Kell, Duffy)

— RBC membrane defects: Hereditary spherocytosis (autosomal dominant, MCHC elevated, EMA flow cytometry), hereditary elliptocytosis, pyropoikilocytosis

— RBC enzyme defects: G6PD deficiency (X-linked, oxidative triggers, bite cells/Heinz bodies), pyruvate kinase deficiency

— Hemoglobinopathies: Alpha-thalassemia (presents earlier than beta due to fetal hemoglobin physiology)

— Sepsis-induced hemolysis and DIC

— Cephalohematoma, subgaleal hemorrhage, intracranial hemorrhage

— Extensive bruising from instrumented delivery

— Polycythemia (IDM, twin-twin transfusion, delayed cord clamping in select contexts)

— Swallowed maternal blood (Apt test differentiates fetal from maternal hemoglobin)

— Gilbert syndrome: UGT1A1 promoter variant, very common, mild lifelong unconjugated hyperbilirubinemia

— Crigler-Najjar type I: Absent UGT1A1, severe (TSB often >30 mg/dL), requires lifelong phototherapy + liver transplant

— Crigler-Najjar type II: Partial UGT1A1, phenobarbital-responsive

— Hypothyroidism: Reduced bilirubin clearance

— Hypopituitarism: Combined hypothyroidism + cortisol deficiency

— Breast milk jaundice

— Pyloric stenosis (delayed gastric emptying → bilirubin reabsorption)

— Intestinal obstruction (duodenal atresia, ileal atresia, meconium ileus, Hirschsprung)

— Cystic fibrosis with meconium ileus

Board pearl: A 3-week-old male with projectile non-bilious vomiting + jaundice = pyloric stenosis — about 5% of cases have associated unconjugated hyperbilirubinemia from reduced glucuronyl transferase and enterohepatic recirculation.

Hemolytic causes (increased bilirubin production):

Non-hemolytic increased production:

Decreased conjugation:

Increased enterohepatic circulation:

Key Differentials — Conjugated (Direct) Hyperbilirubinemia

— Biliary atresia: Most common surgical cause of neonatal cholestasis (~1:10,000-15,000); progressive obliteration of extrahepatic biliary tree; acholic stools, dark urine, hepatomegaly; Kasai portoenterostomy must be performed before 60 days of life for best outcomes

— Choledochal cyst: Palpable RUQ mass possible; ultrasound diagnostic; surgical excision (cancer risk if untreated)

— Inspissated bile syndrome: Following severe hemolysis

— Bile duct stenosis, perforation, gallstones

— Idiopathic neonatal hepatitis: Diagnosis of exclusion

— Infections: TORCH (CMV most common), hepatitis B, HIV, syphilis, listeria, UTI, sepsis

— Metabolic: Galactosemia (E. coli sepsis, cataracts, hepatomegaly — newborn screen), tyrosinemia type I, hereditary fructose intolerance, alpha-1 antitrypsin deficiency (PiZZ), cystic fibrosis, Niemann-Pick C, glycogen storage disease type IV

— Endocrine: Panhypopituitarism (also causes hypoglycemia, micropenis), hypothyroidism, adrenal insufficiency

— Genetic syndromes: Alagille syndrome (bile duct paucity, characteristic facies, butterfly vertebrae, posterior embryotoxon, peripheral pulmonary artery stenosis, JAG1 mutation), progressive familial intrahepatic cholestasis (PFIC) types 1-3

— Toxic: Total parenteral nutrition-associated cholestasis (in preterm infants)

— Cardiac causes (CHF → hepatic congestion)

— Neonatal lupus

Key distinction: Biliary atresia vs. neonatal hepatitis — both present with conjugated hyperbilirubinemia, but biliary atresia typically has acholic stools and firm hepatomegaly, while neonatal hepatitis has more variable presentation. HIDA scan, ultrasound, and liver biopsy help differentiate — never delay surgical consultation if biliary atresia is suspected.

Direct bilirubin >1 mg/dL (or >20% of TSB) is always pathologic — urgent workup required regardless of total bilirubin level

Obstructive (extrahepatic) cholestasis:

Hepatocellular (intrahepatic) cholestasis:

Other:

Discharge Planning, Secondary Prevention, and Long-Term Plan

— Universal TcB or TSB measurement and plot on hour-specific nomogram

— Document gestational age and neurotoxicity risk factors

— Assess feeding adequacy (weight, voids, stools, latch)

— Maternal blood type, Rh, antibody screen reviewed

— Newborn screen sent; hearing screen completed; CCHD pulse oximetry completed

— Family education: signs of jaundice progression, importance of feeding, follow-up appointment scheduled before discharge

— Hepatitis B vaccine #1 given

— Length of stay <24 h → seen by 72 h of life

— 24-48 h stay → seen by 96 h

— 48-72 h stay → seen by 120 h

— Earlier follow-up (within 24 h) for any predischarge TSB in high-risk zone, hemolytic disease, near-term infants, exclusive breastfeeding with weight loss

— Rebound TSB check 12-24 h after discontinuation, especially for hemolytic disease, GA <38 wk, phototherapy started <72 h of life

— Counsel family on jaundice recurrence signs

— NICU monitoring 24-48 h

— ABR hearing test prior to discharge and outpatient audiology follow-up at 3 months

— Developmental surveillance at every well-child visit; refer to early intervention if any delay

— MRI brain if neurologic concerns

— G6PD deficiency: Trigger avoidance list (sulfa drugs, fava beans, naphthalene, primaquine, dapsone, nitrofurantoin in older children); medical alert bracelet

— Hereditary spherocytosis: Folic acid supplementation, monitor hemoglobin, splenectomy in severe cases (after age 5-6), pneumococcal/meningococcal/Hib vaccines pre-splenectomy

— Biliary atresia post-Kasai: Ursodeoxycholic acid, fat-soluble vitamin (ADEK) supplementation, monitor for cholangitis, transplant evaluation

— Congenital hypothyroidism: Levothyroxine titration, TSH/T4 monitoring q1-2 months in infancy

— Crigler-Najjar: Lifelong phototherapy, liver transplant evaluation

Step 3 management: Every newborn discharged should have a scheduled outpatient visit within 1-5 days based on risk stratification — failure to ensure follow-up is a leading root cause in kernicterus malpractice cases.

Predischarge checklist (every newborn):

Follow-up cadence after discharge:

Post-phototherapy plan:

Post-exchange transfusion plan:

Disease-specific long-term management:

Follow-Up, Monitoring Parameters, and Family Counseling

— Weight (compare to birth weight — target regain by 10-14 days; concerning if >10% loss)

— Feeding history: number and duration of feeds, wet diapers, stool frequency/color

— Visual jaundice assessment (cephalocaudal extent)

— TcB or TSB measurement if jaundice present or risk factors warrant

— Recheck TSB at 24-48 h intervals until clearly trending down

— Recommended in some countries (Taiwan, UK) — pale/acholic stools should prompt urgent direct bilirubin measurement to evaluate for biliary atresia

— Counsel parents to call immediately for pale/clay-colored stools or dark tea-colored urine

— 8-12 feeds/day, ensure latch and milk transfer

— Lactation consultant referral if weight loss, jaundice, or maternal nipple pain

— Do NOT recommend water or dextrose supplementation

— Newborn hearing screen (automated ABR is preferred over OAE for bilirubin exposure)

— Repeat ABR at 3 months if any concerns or post-exchange transfusion

— Developmental surveillance at 2, 4, 6, 9, 12 months — refer to early intervention for any delay

— Pediatric neurology referral if abnormal tone, persistent feeding difficulty, or motor delays

— Most jaundice is benign and self-resolving

— Warning signs requiring same-day evaluation: increasing jaundice spreading to legs/palms, poor feeding, lethargy, fever, abnormal cry, arching backward, dark urine, pale stools

— Sunlight exposure through windows is NOT effective treatment

— Continue breastfeeding during phototherapy whenever possible

— Provide written discharge summary including TSB values, treatment received, rebound testing plan

— Communicate directly with outpatient pediatrician for high-risk infants

Board pearl: Auditory neuropathy spectrum disorder (ANSD) can be missed by OAE testing alone — use automated ABR in all infants with significant hyperbilirubinemia history.

Outpatient follow-up visit components:

Stool color card screening:

Breastfeeding optimization:

Developmental and auditory monitoring (post-severe-hyperbilirubinemia):

Family counseling key points:

Documentation and care transitions:

Ethical, Legal, and Patient Safety Considerations

— The Joint Commission and AAP classify kernicterus as a sentinel event — preventable with universal predischarge bilirubin screening, hour-specific nomogram-based decision-making, and timely follow-up

— Root cause analysis required for any case of kernicterus; institutions track these as quality metrics

— Exchange transfusion requires informed consent including ~5-10% morbidity and rare mortality; in true emergencies (ABE in progress), proceed under emergency consent doctrine while attempting to reach parents

— Phototherapy typically requires verbal consent and parental education on duration, monitoring, and risks

— Blood product transfusion refusal (e.g., Jehovah's Witness parents): Parental refusal of life-saving blood transfusion for a minor is NOT legally binding — pursue emergency court order if needed; AAP supports physician obligation to provide life-saving care to children regardless of parental religious objection

— Severe hyperbilirubinemia secondary to failure to seek care in an infant with clear caregiver education and access raises medical neglect concerns — consider social work consultation and, if warranted, CPS referral

— Home births with poor follow-up infrastructure: ensure linkage to care without bias

— Discharge before 48 h of life is a major risk factor for severe hyperbilirubinemia — must have documented follow-up appointment within 24-48 h

— Communicate predischarge TSB, risk factors, and follow-up plan to outpatient pediatrician via direct handoff (not just chart)

— In community hospitals, ensure 24/7 access to phototherapy and rapid TSB results

— Some families use traditional remedies (herbal teas, sunlight exposure, oil rubs, religious practices); acknowledge respectfully and counsel on evidence-based care without dismissing cultural practices

— Use professional interpreters — family interpreters compromise accuracy and confidentiality

— Higher kernicterus rates in racial/ethnic minorities and lower socioeconomic groups — driven by access barriers; advocate for universal screening and follow-up

Step 3 management: For a Jehovah's Witness family refusing exchange transfusion for a neonate with ABE, the correct answer is to obtain emergency court order while initiating maximal phototherapy + IVIG — child's life supersedes parental religious refusal in pediatric emergencies.

Kernicterus as a "never event":

Informed consent edge cases:

Mandatory reporting and child protection:

Transition-of-care safety:

Cultural humility:

Health equity:

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: The mnemonic for prolonged unconjugated jaundice in a well-appearing breastfed infant >2 weeks: "BUG-CHIP" — Breast milk, UTI, Gilbert/Crigler-Najjar, Congenital hypothyroidism, Hereditary spherocytosis, Intestinal obstruction (pyloric stenosis), Physiologic (rare to persist this long).

Jaundice in first 24 hours = ALWAYS pathologic — most often isoimmune hemolysis

Mother O, baby A or B + positive DAT = ABO isoimmune hemolytic disease (most common US cause)

Mother Rh-negative, no RhoGAM, baby Rh-positive = Rh hemolytic disease, often severe

Cephalohematoma + jaundice day 2-3 = resorbing blood load

Breastfed, day 3-5, poor feeding, >10% weight loss = breastfeeding (suboptimal intake) jaundice → increase feeds

Breastfed, day 5-14, thriving infant, weeks-long jaundice = breast milk jaundice → reassurance

Acholic stools + dark urine + direct hyperbilirubinemia in 4-week-old = biliary atresia → urgent Kasai before 60 days

Vomiting + cataracts + hepatomegaly + E. coli sepsis + jaundice = galactosemia → galactose-free formula

Jaundice + macroglossia + umbilical hernia + hypotonia + constipation = congenital hypothyroidism

Jaundice + hypoglycemia + micropenis = panhypopituitarism

Jaundice + characteristic facies + butterfly vertebrae + posterior embryotoxon + peripheral pulmonary stenosis = Alagille syndrome

Mediterranean/African/Asian male infant + jaundice after sulfa drug or fava bean exposure = G6PD deficiency

Family history of splenectomy or gallstones in childhood + spherocytes on smear = hereditary spherocytosis

TSB >30 mg/dL in first week + persistent throughout life = Crigler-Najjar type I (Type II responds to phenobarbital)

MRI: bilateral globus pallidus T2 hyperintensity = kernicterus

Bronze baby syndrome = phototherapy in conjugated hyperbilirubinemia

Pyloric stenosis + jaundice = ~5% association, reduced glucuronyl transferase activity

Auditory neuropathy is a signature kernicterus finding — use ABR, not OAE

RhoGAM at 28 weeks + within 72 h postpartum if baby Rh+

Kasai operation ideal <60 days; outcomes poor after 90 days

Hour-specific nomogram (AAP 2022) is the diagnostic backbone

Board Question Stem Patterns

Key distinction: Watch for timing cues in every stem — they almost always point directly to the diagnosis.

Stem 1 — "Jaundice in first 12 hours": Term infant born to O-positive mother, baby blood type A, jaundice noted at 10 hours of life, TSB 12 mg/dL. Answer: Obtain direct Coombs, CBC with retic, blood smear; initiate phototherapy; consider IVIG if DAT positive and TSB rising.

Stem 2 — "Persistent jaundice in 4-week-old": Breastfed infant, jaundice persists at 4 weeks, acholic stools, dark urine, firm hepatomegaly. Answer: Fractionated bilirubin (direct elevated) → abdominal ultrasound + HIDA scan → urgent pediatric surgery consult for biliary atresia / Kasai.

Stem 3 — "Lethargic jaundiced neonate": Day 5, TSB 28 mg/dL, infant arching backward with high-pitched cry. Answer: Acute bilirubin encephalopathy — start intensive phototherapy immediately, IVIG if isoimmune, prepare double-volume exchange transfusion, NICU.

Stem 4 — "Breastfed infant, weight loss": 5-day-old exclusively breastfed, lost 11% birth weight, TSB 18 mg/dL, last wet diaper 12 h ago. Answer: Lactation consultant, increase feeding frequency, supplement formula if needed, recheck TSB in 6-12 h, phototherapy if at threshold.

Stem 5 — "Mediterranean male infant": 3-day-old, mother ate fava beans postpartum, jaundice, anemia, bite cells on smear. Answer: G6PD deficiency — phototherapy, counsel family on lifelong trigger avoidance.

Stem 6 — "Vomiting and cataracts": 1-week-old with jaundice, vomiting after feeds, bilateral cataracts, hepatomegaly, E. coli bacteremia. Answer: Galactosemia — stop lactose/galactose feeds, soy formula, send GALT enzyme assay.

Stem 7 — "Prolonged jaundice + cold intolerance": 3-week-old with prolonged jaundice, large posterior fontanelle, hypotonia, constipation, umbilical hernia. Answer: Check newborn screen TSH — congenital hypothyroidism → levothyroxine.

Stem 8 — "Hemolysis without retic response": Newborn with hemolytic anemia, low reticulocyte count despite anemia. Answer: Consider parvovirus B19 or G6PD (which may show suppressed retic).

Stem 9 — "Pyloric stenosis + jaundice": 3-week-old male with projectile non-bilious vomiting, palpable olive, mild jaundice. Answer: Pyloromyotomy; jaundice resolves after surgical correction.

Stem 10 — "Discharge planning": Term infant discharged at 36 h, TSB in high-intermediate risk zone. Answer: Outpatient follow-up within 24 h with repeat TSB.

One-Line Recap

High-yield rapid recaps:

Board pearl: When in doubt on Step 3, the right next step is almost always — measure TSB, fractionate it, plot on the hour-specific nomogram, and ensure 24-48 hour follow-up after discharge. These four moves prevent virtually all preventable kernicterus.

The core teaching point: Neonatal jaundice in the first 24 hours, with direct bilirubin elevation, with rapid rise, or persisting beyond 2 weeks is pathologic until proven otherwise — risk-stratify every infant on the AAP 2022 hour-specific nomogram with gestational age and neurotoxicity factors, treat with intensive phototherapy (and IVIG/exchange transfusion in severe isoimmune hemolytic disease), and never miss biliary atresia as the time-sensitive surgical cause of conjugated hyperbilirubinemia.

Always pathologic features: Onset <24 h, TSB rising >0.2 mg/dL/hr or >5 mg/dL/day, TSB above hour-specific phototherapy threshold, direct bilirubin >1 mg/dL or >20% of TSB, persistent jaundice >2 weeks term/>3 weeks preterm, sick-appearing infant

Workup bundle for elevated TSB: Fractionated bilirubin, CBC with smear, reticulocyte, direct Coombs, blood type, albumin — plot on nomogram, then decide phototherapy vs. observation vs. escalation

Treatment ladder: Optimize feeding → phototherapy at threshold → intensive phototherapy + IVIG (if isoimmune) → double-volume exchange transfusion (if at exchange threshold or any signs of ABE)

Never miss diagnoses: Biliary atresia (Kasai <60 days), galactosemia (E. coli sepsis), congenital hypothyroidism (developmental disability), G6PD deficiency (preventable hemolytic crises), acute bilirubin encephalopathy (kernicterus is a never event)